Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.84 USD | +4.48% | +2.31% | +47.37% |
14/05 | Viracta Therapeutics Appoints Michael Faerm CFO | MT |
14/05 | Viracta Therapeutics, Inc. Appoints Michael Faerm as Chief Financial Officer | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+47.37% | 3.16Cr | |
+29.77% | 4.92TCr | |
+1.00% | 4.21TCr | |
+50.47% | 4.04TCr | |
-5.26% | 2.89TCr | |
+13.68% | 2.61TCr | |
-22.99% | 1.87TCr | |
+8.22% | 1.33TCr | |
+32.41% | 1.23TCr | |
-1.62% | 1.2TCr |
- Stock Market
- Equities
- VIRX Stock
- News Viracta Therapeutics, Inc.
- Viracta's Lymphoma Drug Candidate Granted European Commission's Orphan Drug Designation